Clinical Value of NGAL, L-FABP and Albuminuria in Predicting GFR Decline in Type 2 Diabetes Mellitus Patients

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Chou, Kuei Mei ^a   Lee, Chin Chan ^a   Chen, Chih Huang ^a   Sun, Chiao Yin ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; LIVER TYPE FATTY ACID BINDING PROTEIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; UNCLASSIFIED DRUG;

ADULT; ALBUMINURIA; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY INJURY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; REFERENCE VALUE; URINARY EXCRETION;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FATTY ACID-BINDING PROTEINS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LIPOCALINS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS;

EID: 84872806766     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054863     Document Type: Article

References (39)

1. Rossing P, (2006) Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history. Curr Diab Rep 6: 479-483.
2. Neilsen SE, Schjoedt KJ, Rossing P, (2010) Neutrophil Gelatinase-Associated Lipocalcin (NGAL) and Kidney Injury Molecule (KIM1) in patients with diabetes nephropathy: a cross-sectional study and the effects of lisinopril. Diabet Med 27: 1144-1150.
3. Fioretto P, Steffes MW, Brown DM, Mauer SM, (1992) An overview of renal pathology in insulin-dependent diabetes mellitus in relationship to altered glomerular hemodynamics. Am J Kidney Dis 20: 549-558.
4. Nickolas TL, Barasch J, Devarajan P, (2008) Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens 17: 127-132.
5. Dronavalli S, Duka I, Bakris GL, (2008) The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 4: 444-452.
6. de Zeeuw D, Ramjit D, Zhang Z, Ribeiro AB, Kurokawa K, et al. (2006) Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL. Kidney Int 69: 1675-1682.
7. Ruggenenti P, Remuzzi G, (2006) Time to abandon microalbuminuria?. Kidney Int 70: 1214-1222.
8. Dinneen SF, Gerstein HC, (1997) The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 157: 1413-1418.
9. Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, et al. (2009) Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol 20: 1813-1821.
10. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, Jensen G, Clausen P, et al. (2004) Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 110: 32-35.
11. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, et al. (2003) Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 63: 225-232.
12. Yamazaki M, Tani N, Igarashi K, Nakamura H, Momotsu T, et al. (1991) Changes in the glomerular pore size selectivity in patients with type II diabetes mellitus. J Diabet Complications 5: 138-139.
13. Devarajan P, (2010) Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med 4: 265-280.
14. McMahon BA, Murray PT, (2010) Urinary liver fatty acid-binding protein: another novel biomarker of acute kidney injury. Kidney Int 77: 657-659.
15. Yang J, Mori K, Li JY, Barasch J, (2003) Iron, lipocalin, and kidney epithelia. Am J Physiol Renal Physiol 285: F9-F18.
16. Kamijo A, Sugaya T, Hikawa A, Yamanouchi M, Hirata Y, et al. (2006) Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem 284: 175-182.
17. Bataille A, Abbas S, Semoun O, Bourgeois É, Marie O, et al. (2011) Plasma neutrophil gelatinase-associated lipocalin in kidney transplantation and early renal function prediction. Transplantation 92: 1024-1030.
18. Adler S, (2004) Diabetic nephropathy: Linking histology, cell biology, and genetics. Kidney Int 66: 2095-2106.
19. Kamijo A, Kimura K, Sugaya T, Yamanouchi M, Hikawa A, et al. (2004) Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 143: 23-30.
20. Fu WJ, Li BL, Wang SB, Chen ML, Deng RT, et al. (2012) Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration. Diabetes Res Clin Pract 95: 105-109.
21. Fu WJ, Xiong SL, Fang YG, Wen S, Chen ML, et al. (2012) Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Endocrine 41: 82-88.
22. Nielsen SE, Andersen S, Zdunek D, Hess G, Parving HH, et al. (2011) Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney Int 79: 1113-1118.
23. Nielsen SE, Hansen HP, Jensen BR, Parving HH, Rossing P, (2011) Urinary neutrophil gelatinase-associated lipocalin and progression of diabetic nephropathy in type 1 diabetic patients in a four-year follow-up study. Nephron Clin Pract 118: 130-135.
24. American Diabetes Association, (2012) Standards of medical care in diabetes-2012. Diabetes Care. 35: S11-S63.
25. Gray SP, Cooper ME, (2011) Diabetic nephropathy in 2010: Alleviating the burden of diabetic nephropathy. Nat Rev Nephrol 7: 71-73.
26. Vallon V, Thomson SC, (2012) Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu Rev Physiol 74: 351-375.
27. Najafian B, Alpers CE, Fogo AB, (2011) Pathology of human diabetic nephropathy. Contrib Nephrol 170: 36-47.
28. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Fazio MR, et al. (2009) Neutrophil gelatinase-associated lipocalin as an early biomarker of nephropathy in diabetic patients. Kidney Blood Press Res 32: 91-98.
29. Nauta FL, Boertien WE, Bakker SJ, van Goor H, van Oeveren W, et al. (2011) Glomerular and tubular damage markers are elevated in patients with diabetes. Diabetes Care 34: 975-981.
30. Nielsen SE, Sugaya T, Hovind P, Baba T, Parving HH, et al. (2010) Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients. Diabetes Care 33: 1320-1324.
31. Kim SS, Song SH, Kim IJ, Yang JY, Lee JG, et al. (2012) Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients. Diabetes Res Clin Pract 97: 251-257.
32. Bhavsar NA, Köttgen A, Coresh J, Astor BC, (2012) Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM-1) as Predictors of Incident CKD Stage 3: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 60: 233-240.
33. Deferrari G, Repetto M, Calvi C, Ciabattoni M, Rossi C, et al. (1998) Diabetic nephropathy: from micro- to macroalbuminuria. Nephrol Dial Transplant 13: S11-S15.
34. Cooper ME, (1998) Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 352: 213-219.
35. Nangaku M, (2004) Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med 43: 9-17.
36. Vallon V, Thomson SC, (2012) Renal function in diabetic disease models: the tubular system in the pathophysiology of the diabetic kidney. Annu Rev Physiol 74: 351-375.
37. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, et al. (1984) Structural-functional relationships in diabetic nephropathy. J Clin Invest 74: 1143-1155.
38. Bohle A, Wehrmann M, Bogenschütz O, Batz C, Müller CA, et al. (1991) The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. Pathol Res Pract 187: 251-259.
39. Phillips AO, Steadman R, (2002) Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury. Histol Histopathol 17: 247-252.